Brivanib alaninate
- Catalog NO.:A20636
- CAS No. : 649735-63-7
- Molecular Formula:C22H24FN5O4
- Molecular Weight: 441.46
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 649735-63-7 | Appearance | White powder |
Catalog Number | A20636 | MDL Number | MFCD22577162 |
Molecular Formula | C22H24FN5O4 | Molecular Weight | 441.46 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | BMS-582664;(S)-(R)-1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-yl 2-aminopropanoate | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Danger | UN Number | 2811 |
Hazard Statements | H302-H360 | Class | 6.1 |
Precautionary Statements | P201-P308+P313 | Packing Group | Ⅲ |
Description
Brivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. |